Roberta Ferraldeschi
Cambridge, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 47 publications
Reply to Felix Melchior, Andreas Pircher, and Isabel Heidegger's Letter to the Editor re: Johann S. de Bono, Meng He, Chen Shi, et al. Final Overall Survival and Molecular Data Associated with Clinical Outcomes in Patients Receiving Ipatasertib and Abiraterone in the Phase 3 IPATential150 Trial. Eur Urol. 2025;87:468-75.
Journal: European urology
Published: March 13, 2025
Cabozantinib plus atezolizumab in metastatic prostate cancer (CONTACT-02): final analyses from a phase 3, open-label, randomised trial.
Journal: The Lancet. Oncology
Published: February 27, 2025
Antagonism of inhibitors of apoptosis proteins reveals a novel, immune response-based therapeutic approach for T-cell lymphoma.
Journal: Blood advances
Published: December 02, 2020
ASTX029, a Novel Dual-mechanism ERK Inhibitor, Modulates Both the Phosphorylation and Catalytic Activity of ERK.
Journal: Molecular cancer therapeutics
Published: October 26, 2020
First-in-Human Study of AT13148, a Dual ROCK-AKT Inhibitor in Patients with Solid Tumors.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: February 24, 2020
A Phase I Study of ASTX660, an Antagonist of Inhibitors of Apoptosis Proteins, in Adults with Advanced Cancers or Lymphoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: June 25, 2019
Pharmacodynamic and Clinical Results from a Phase I/II Study of the HSP90 Inhibitor Onalespib in Combination with Abiraterone Acetate in Prostate Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: November 07, 2018
Immunomodulatory Properties of DNA Hypomethylating Agents: Selecting the Optimal Epigenetic Partner for Cancer Immunotherapy.
Journal: Frontiers in pharmacology
Published: August 10, 2018
Docetaxel Treatment in PTEN- and ERG-aberrant Metastatic Prostate Cancers.
Journal: European urology oncology
Published: February 12, 2018
Gene Copy Number Estimation from Targeted Next-Generation Sequencing of Prostate Cancer Biopsies: Analytic Validation and Clinical Qualification.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: April 04, 2017
Drug discovery in advanced prostate cancer: translating biology into therapy.
Journal: Nature reviews. Drug discovery
Published: July 23, 2016
Last Updated: 09/26/2026